2772-4174

European Journal of Medicinal Chemistry Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 347 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact347 DOIs
2

Attach ORCID iDs across 56 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact56 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 347 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Therapeutic role of flavonoids and flavones in cancer preven… (10.1016/j.ejmcr.2021.100010)
Abstract ORCID
84.51 48
2 Green and chemical syntheses of silver nanoparticles: Compar… (10.1016/j.ejmcr.2024.100168)
Abstract ORCID
74.57 30
3 Bioavailability enhancement of curcumin via esterification p… (10.1016/j.ejmcr.2022.100081)
Abstract ORCID
68.09 22
4 Comprehensive review of DNA gyrase as enzymatic target for d… (10.1016/j.ejmcr.2024.100233)
Abstract ORCID
68.09 22
5 Design, synthesis of new 2,4-thiazolidinediones: In-silico,… (10.1016/j.ejmcr.2024.100151)
Abstract ORCID
66.11 20
6 Experimental and computational models to understand protein-… (10.1016/j.ejmcr.2024.100133)
Abstract ORCID
65.05 19
7 Design, synthesis and structure-activity studies of amino ac… (10.1016/j.ejmcr.2022.100087)
Abstract ORCID
61.52 16
8 Strategic application of CuAAC click chemistry in the modifi… (10.1016/j.ejmcr.2023.100113)
Abstract ORCID
60.21 15
9 Advancements, challenges, and future frontiers in covalent i… (10.1016/j.ejmcr.2024.100217)
Abstract ORCID
60.21 15
10 Design, synthesis, characterization and antidiabetic evaluat… (10.1016/j.ejmcr.2024.100213)
Abstract ORCID
58.80 14
11 In vitro antimicrobial combat, molecular modelling and struc… (10.1016/j.ejmcr.2022.100048)
Abstract ORCID
53.96 11
12 Review on canthin-6-one alkaloids: Distribution, chemical as… (10.1016/j.ejmcr.2022.100049)
Abstract ORCID
53.96 11
13 Thiazole, triazole, thio- and semicarbazone derivatives - Pr… (10.1016/j.ejmcr.2021.100002)
Abstract ORCID
52.07 10
14 Synthesis and biological activity of bisindole derivatives a… (10.1016/j.ejmcr.2022.100076)
Abstract ORCID
52.07 10
15 Emerging insights into the structure-activity relationship o… (10.1016/j.ejmcr.2023.100122)
Abstract ORCID
50.00 9
16 Hydroxyapatite–polymer nanocomposites for drug delivery appl… (10.1016/j.ejmcr.2024.100231)
Abstract ORCID
50.00 9
17 Recent advances on anticancer activity of coumarin derivativ… (10.1016/j.ejmcr.2022.100038)
Abstract
49.78 97
18 Pharmacology of caffeine and its effects on the human body (10.1016/j.ejmcr.2024.100138)
Abstract
48.36 85
19 Vanillin: A food additive with multiple biological activitie… (10.1016/j.ejmcr.2022.100055)
Abstract
48.11 83
20 Green nanoparticle formation toward wound healing, and its a… (10.1016/j.ejmcr.2022.100088)
Abstract ORCID
47.71 8
21 Matrine family derivatives: Synthesis, reactions procedures,… (10.1016/j.ejmcr.2022.100098)
Abstract ORCID
47.71 8
22 Herbal nanogels: Revolutionizing skin cancer therapy through… (10.1016/j.ejmcr.2023.100126)
Abstract ORCID
45.15 7
23 Matrix metalloproteinase-8 (MMP-8) and its inhibitors: A min… (10.1016/j.ejmcr.2024.100130)
Abstract ORCID
45.15 7
24 Natural acetylcholinesterase inhibitors: A multi-targeted th… (10.1016/j.ejmcr.2024.100154)
Abstract
43.31 53
25 A convenient total synthesis of PSMA-617: A prostate specifi… (10.1016/j.ejmcr.2022.100084)
Abstract ORCID
42.25 6
26 Quinoxaline: A comprehension of current pharmacological adva… (10.1016/j.ejmcr.2022.100040)
Abstract
40.84 42
27 Advances in synthesis, medicinal properties and biomedical a… (10.1016/j.ejmcr.2024.100210)
Abstract
40.84 42
28 A comprehensive review on pyrazoline based heterocyclic hybr… (10.1016/j.ejmcr.2022.100042)
Abstract
40.58 41
29 Recent progress of surface plasmon resonance in the developm… (10.1016/j.ejmcr.2021.100003)
Abstract ORCID
38.91 5
30 Total chemical synthesis of PSMA-11: API for 68Ga-PSMA-11 us… (10.1016/j.ejmcr.2021.100014)
Abstract ORCID
38.91 5
31 A comprehensive review of cycloastragenol: Biological activi… (10.1016/j.ejmcr.2022.100060)
Abstract ORCID
38.91 5
32 Traditional medicinal plants used for rheumatoid arthritis a… (10.1016/j.ejmcr.2024.100146)
Abstract ORCID
38.91 5
33 Indoles in drug design and medicinal chemistry (10.1016/j.ejmcr.2025.100252)
Abstract
36.93 29
34 Exploring the medicinal significance of l-Arginine mediated… (10.1016/j.ejmcr.2024.100175)
Abstract
36.18 27
35 Oxadiazole derivatives: Histone deacetylase inhibitors in an… (10.1016/j.ejmcr.2022.100058)
Abstract
35.37 25
36 Nanotechnology-based drug delivery for breast cancer treatme… (10.1016/j.ejmcr.2025.100268)
Abstract
35.37 25
37 The use of heterocyclic-based azo compounds bearing pyrrolid… (10.1016/j.ejmcr.2021.100001)
Abstract ORCID
34.95 4
38 Flavonoid-liposomes formulations: Physico-chemical character… (10.1016/j.ejmcr.2022.100059)
Abstract
34.95 24
39 Understanding the mechanism of ulcerative colitis-induced co… (10.1016/j.ejmcr.2024.100161)
Abstract ORCID
34.95 4
40 Phytochemistry and pharmacological activities of essential o… (10.1016/j.ejmcr.2024.100201)
Abstract ORCID
34.95 4
41 Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-… (10.1016/j.ejmcr.2021.100013)
Abstract
34.51 23
42 Anti inflammatory properties and safety of green synthesized… (10.1016/j.ejmcr.2024.100169)
Abstract
34.04 22
43 Polyphenol encapsulated nanofibers in wound healing and drug… (10.1016/j.ejmcr.2024.100184)
Abstract
33.56 21
44 Novel 1,2,3-triazole-aurone hybrids as cathepsin B inhibitor… (10.1016/j.ejmcr.2022.100056)
Abstract
33.06 20
45 Chalcone: A potential scaffold for NLRP3 inflammasome inhibi… (10.1016/j.ejmcr.2022.100100)
Abstract
33.06 20
46 Current trends in silica based drug delivery systems (10.1016/j.ejmcr.2024.100206)
Abstract
31.97 18
47 Discovery and current developments of isoindolinone-based fu… (10.1016/j.ejmcr.2023.100112)
Abstract
31.38 17
48 Thiazolidinedione an auspicious scaffold as PPAR-γ agonist:… (10.1016/j.ejmcr.2024.100160)
Abstract
31.38 17
49 A review on progress of thiazole derivatives as potential an… (10.1016/j.ejmcr.2024.100225)
Abstract
31.38 17
50 Pyrimidine analogues for the management of neurodegenerative… (10.1016/j.ejmcr.2022.100095)
Abstract
30.10 15